Details of the Drug Reposition

General Information of This Drug (ID: DM6GJTS)

• Drug Name: RG6237 (DM6GJTS)

Information on Drug Reposition of This Drug

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Spinal muscular atrophy	DISTLKOB	8B61	Phase 2	[1]
facioscapulohumeral muscular dystrophy	DISSE0H0	8C70	Phase 2	[1]

References

• [1] Clinical pipeline report, company report or official report of Roche